https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reevaluation-de-rebinynmc-nonacog-beta-pegol-hemophilie-de-type-b.html 2021 Canada drug evaluation nonacog beta pegol beta, nos nonacog beta pegol
--- https://www.has-sante.fr/portail/jcms/c_2825852/fr/refixia 2018 false false false false France French evaluation of the transparency committee nonacog beta pegol coagulation factor IX hemorrhage hemorrhage treatment outcome hemophilia B injections, intravenous factor IX polyethylene glycols recombinant proteins
--- Refixia - nonacog beta pegol https://www.ema.europa.eu/medicines/human/EPAR/Refixia 2017 false false false United Kingdom French English syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe nonacog beta pegol nonacog beta pegol coagulation factor IX treatment outcome product surveillance, postmarketing hemorrhage hemorrhage hemophilia B hemophilia B adult adolescent aged injections, intravenous drug evaluation, preclinical factor IX polyethylene glycols recombinant proteins factor IX polyethylene glycols recombinant proteins